Novo Nordisk
Pharma

Novo shares plummet on sales, profit warning for '26

Novo turned in sales and profit growth in 2025 amid an intense obesity market rivalry with Lilly. This year, the company is forecasting declines.
Eric Sagonowsky Feb 3, 2026 2:00pm
space launch rocketship

Top 10 most anticipated drug launches of 2026

Feb 2, 2026 3:00am
4x3png

Why Innovation Matters in First-Line HER2+ GEA

Feb 2, 2026 8:00am
Flag of India on a pole and billowing in the wind Behind the flag is greenery

Biologics, biosimilars are the focus of India's $1.1B investment

Feb 3, 2026 2:35pm
Why human expertise still matters in AI-driven med comms

Why human expertise still matters in AI-driven med comms

Feb 2, 2026 8:00am
Food and Drug Administration

Regulatory tracker: AZ, Daiichi's Datroway gains speedy FDA review

Feb 3, 2026 2:30pm
More News
Fierce Biotech

Charles River to close Maryland CDMO site, lay off 20 staffers

Feb 3, 2026 12:20pm

Merck lines up $70B+ in revenue opportunities over next decade

Feb 3, 2026 12:14pm
Fierce Biotech

FDA to ‘carefully shepherd’ CAR-T for autoimmune disease: Prasad

Feb 3, 2026 11:40am

BMS, J&J factor in HCP education before milvexian data drop

Feb 3, 2026 10:15am